Kynam Capital Management »

Dynavax Technologies shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Dynavax Technologies (DVAX) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Dynavax Technologies

Tip: Access up to 7 years of quarterly data

All positions including Dynavax Technologies held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dynavax Technologies by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $80M 7.1M 11.23
2024-03-31 $53M 4.2M 12.41
2023-12-31 $21M 1.5M 13.98
2023-09-30 $7.4M 500k 14.77

More positions owned by Kynam Capital Management

Natera (NTRA)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dynavax Technologies Corp Com New (DVAX)
Cogent Biosciences (COGT)
Insmed Com Par $.01 Call Option (INSM)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
BioCryst Pharmaceuticals (BCRX)
Protagonist Therapeutics (PTGX)
2seventy Bio Common Stock (TSVT)
Miragen Therapeutics (VRDN)
Wave Life Sciences SHS (WVE)

View all positions for Kynam Capital Management

Top funds holding Dynavax Technologies

BlackRock
BlackRock
Deep Track Capital
Vanguard Group
State Street Corporation
Kynam Capital Management
Federated Investors
Chicago Capital
Goldman Sachs Group
Dimensional Fund Advisors
Geode Capital Management
Morgan Stanley
William Blair $ Company
Renaissance Technologies
Tang Capital Management

View all funds holding Dynavax Technologies